Understanding Cervical Cancer through Proteomics.

Understanding Cervical Cancer through Proteomics.
复制标题

DOI:
10.3390/cells10081854
复制
发表时间:
2021-07-22
期刊:
影响因子:
6
通讯作者:
Mendoza-Almanza G
Mendoza-Almanza G
中科院分区:
生物学2区
文献类型:
--
作者:
Martínez-Rodríguez F;Limones-González JE;Mendoza-Almanza B;Esparza-Ibarra EL;Gallegos-Flores PI;Ayala-Luján JL;Godina-González S;Salinas E;Mendoza-Almanza G

文献摘要

参考文献

被引文献

相似文献

癌症是全球主要的公共卫生问题之一,癌症患者的数量每天都在增加。特别是,宫颈癌(CC)仍然是发展中国家妇女癌症死亡的第二大原因。因此,有必要加深我们对CC的分子发病机制的认识,并提出新的治疗靶点和新的方法来早期诊断这种疾病。使用应用于生物样品的高通量技术的差异表达分析允许确定正常细胞的生理状态和癌症发展产生的变化。在疾病中分析基因组、转录组或蛋白质组中的差异分子谱簇,并且其被称为癌症的分子特征。蛋白质组学分析的生物样品的患者与不同级别的宫颈上皮内瘤样病变(CIN)和CC已用于阐明参与的发展和进展的癌症的途径,并确定与CC相关的宫颈蛋白。然而,一些宫颈癌的发生机制仍不清楚。在最早阶段检测病理可以显着提高患者的生存率,预后和复发。本文就CC的蛋白质组学研究进展作一综述。
Cancer is one of the leading public health issues worldwide, and the number of cancer patients increases every day. Particularly, cervical cancer (CC) is still the second leading cause of cancer death in women from developing countries. Thus, it is essential to deepen our knowledge about the molecular pathogenesis of CC and propose new therapeutic targets and new methods to diagnose this disease in its early stages. Differential expression analysis using high-throughput techniques applied to biological samples allows determining the physiological state of normal cells and the changes produced by cancer development. The cluster of differential molecular profiles in the genome, the transcriptome, or the proteome is analyzed in the disease, and it is called the molecular signature of cancer. Proteomic analysis of biological samples of patients with different grades of cervical intraepithelial neoplasia (CIN) and CC has served to elucidate the pathways involved in the development and progression of cancer and identify cervical proteins associated with CC. However, several cervical carcinogenesis mechanisms are still unclear. Detecting pathologies in their earliest stages can significantly improve a patient’s survival rate, prognosis, and recurrence. The present review is an update on the proteomic study of CC.
DOI: 10.1016/s1470-2045(10)70230-8
发表时间: 2010-11-01
期刊: LANCET ONCOLOGY
影响因子: 51.1
作者:
de Sanjose, Silvia;Quint, Wim G. V.;Xavier Bosch, F.
通讯作者: Xavier Bosch, F.
DOI: 10.1186/1752-0509-5-96
发表时间: 2011-06-22
影响因子: --
作者:
Higareda-Almaraz JC;Enríquez-Gasca Mdel R;Hernández-Ortiz M;Resendis-Antonio O;Encarnación-Guevara S
通讯作者: Encarnación-Guevara S
DOI: 10.33176/aacb-19-00023
发表时间: 2019-08-01
期刊: The Clinical biochemist. Reviews
影响因子: --
作者:
Allen, Darren R;McWhinney, Brett C
通讯作者: McWhinney, Brett C
DOI: 10.1002/pmic.200800387
发表时间: 2008-12
期刊: PROTEOMICS
影响因子: 3.4
作者:
Zong, Chenggong;Young, Glen W.;Wang, Yueju;Lu, Haojie;Deng, Ning;Drews, Oliver;Ping, Peipei
通讯作者: Ping, Peipei
DOI: 10.1038/s41571-018-0002-6
发表时间: 2018-06
期刊: Nature reviews. Clinical oncology
影响因子: --
作者:
Berger MF;Mardis ER
通讯作者: Mardis ER